Focus Partners Advisor Solutions’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.42M Sell
122,407
-11,900
-9% -$694K 0.07% 125
2025
Q4
$7.24M Buy
134,307
+62,870
+88% +$3.02M 0.09% 106
2025
Q3
$3.34M Buy
71,437
+40,340
+130% +$1.88M 0.04% 235
2025
Q2
$1.44M Buy
31,097
+1,879
+6% +$92.2K 0.02% 347
2025
Q1
$1.78M Buy
29,218
+2,164
+8% +$126K 0.03% 274
2024
Q4
$1.53M Sell
27,054
-17,359
-39% -$970K 0.03% 264
2024
Q3
$2.3M Buy
44,413
+5,630
+15% +$264K 0.05% 182
2024
Q2
$1.61M Buy
38,783
+555
+1% +$24.8K 0.04% 189
2024
Q1
$2.07M Buy
38,228
+26,208
+218% +$1.34M 0.06% 154
2023
Q4
$617K Sell
12,020
-21,175
-64% -$1.11M 0.03% 216
2023
Q3
$1.93M Buy
33,195
+22,084
+199% +$1.35M 0.09% 105
2023
Q2
$711K Buy
11,111
+849
+8% +$56.9K 0.04% 171
2023
Q1
$711K Sell
10,262
-537
-5% -$37.9K 0.05% 162
2022
Q4
$777K Sell
10,799
-13,918
-56% -$1.05M 0.06% 146
2022
Q3
$1.76M Buy
24,717
+12,240
+98% +$888K 0.1% 99
2022
Q2
$961K Buy
12,477
+4,812
+63% +$366K 0.08% 120
2022
Q1
$561K Buy
+7,665
New +$515K 0.06% 159

Other funds holding BMY

Focus Partners Advisor Solutions's BMY Position: Q1 2026 in Review

Focus Partners Advisor Solutions reduced its Bristol-Myers Squibb (BMY) stake by 8.9% in Q1 2026, selling an estimated $694K and leaving 122,407 shares worth $7.42M. The position accounts for 0.07% of the portfolio, ranked #125.

Focus Partners Advisor Solutions first reported a position in BMY in Q1 2022 and has held it in 17 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Focus Partners Advisor Solutions held 122,407 shares of Bristol-Myers Squibb worth $7.42M as of Q1 2026.
  • Focus Partners Advisor Solutions sold 11,900 Bristol-Myers Squibb shares in Q1 2026, an estimated $694K.
  • Bristol-Myers Squibb made up 0.07% of Focus Partners Advisor Solutions's portfolio in Q1 2026, its #125 holding.
  • Focus Partners Advisor Solutions first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 17 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q1 2026, filed 13 May 2026.